MicroRNA Market Outlook 2024-2033: Trends and Projections

Market Size – The microRNA market size has grown rapidly in recent years. It will grow from $1.12 billion in 2023 to $1.33 billion in 2024 at a compound annual growth rate (CAGR) of 18.3%. The growth in the historic period can be attributed to discovery of microRNAs, RNA interference (RNAi), genome sequencing projects, computational biology and bioinformatics, and extracellular vehicles (EVs) research.

The microRNA market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2028 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to clinical translation, regulatory networks and systems biology, microRNA-based therapeutics, therapeutic potential, and biomarker discovery. Major trends in the forecast period include technological advances, bioinformatics and data analysis, cross-species conservation, microbiome interactions, and functional mechanisms.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

Scope Of MicroRNA MarketThe Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

MicroRNA Market Overview

Market Drivers –The increasing number of cancer cases is expected to propel the growth of the microRNA market going forward. Cancer refers to a complex disease characterized by uncontrolled cell growth and proliferation, often leading to the formation of malignant tumors that can invade surrounding tissues and spread to distant organs, posing significant health risks. The increasing number of cancer cases is due to various factors, including aging populations, lifestyle choices such as smoking and poor diet, environmental pollutants, and improved detection methods leading to earlier diagnosis. MicroRNA is combined with traditional cancer therapies to enhance drug sensitivity and improve outcomes. Beyond treatment, miRNAs serve as diagnostic and prognostic biomarkers, helping to identify cancer types, predict disease progression, and monitor treatment responses. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, around 20 million new cases and 9.7 million cancer-related deaths were recorded annually in 2022, and predictions indicate that by 2040, there would be 15.3 million deaths and 29.9 million new cases per year. Therefore, the increasing number of cancer cases is driving the growth of the microRNA market.

Market Trends – Major companies operating in the microRNA market are focusing on developing advanced solutions such as MiRNA probe customization services to meet the specific needs of researchers and clinicians, enhance the accuracy of miRNA detection, and facilitate a wide range of applications. MiRNA probe customization services refer to specialized services offered by biotechnology and molecular biology companies to design and produce customized probes specific to particular microRNAs (miRNAs) for various research and clinical applications. For instance, in September 2023, Abnova Corporation, a Taiwan-based biotech company, launched enhanced services for customizing miRNA probes, along with a new range of cataloged miRNA probes, to meet the diverse needs of academic, industrial, and research communities engaged in miRNA research. These probes play a crucial role in identifying and precisely locating miRNAs, which are small, non-coding RNA molecules vital for various biological processes. Abnova’s customization services ensure high specificity and minimal cross-reactivity, making them well-suited for analyzing samples with limited miRNA content.

The microRNA market covered in this report is segmented –

1) By Products: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, miRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations

Get an inside scoop of the microrna market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

Regional Insights – North America was the largest region in the microRNA market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies – Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc, Sistemic Scotland Limited

Table of Contents 1. Executive Summary2. MicroRNA Market Report Structure3. MicroRNA Market Trends And Strategies4. MicroRNA Market – Macro Economic Scenario5. MicroRNA Market Size And Growth…..27. MicroRNA Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model